Search
Back 

2017 Announcements

2017 Announcements

June 12, 2017

NCI/CTEP Registration and Credential Repository (RCR)
The NCI will launch the Registration and Credential Repository (RCR) on July 31, 2017. Click here for information about recommended steps to take.  Information will be presented at the NRG Oncology Meeting, Thursday, July 13, 2017. Site staff  are also strongly encouraged to read the RCR and Delegation Task Log (DTL) section (pages 4-6) of the CTSU's Newsletter (Spring 2017 Edition).  The newsletter is posted to the CTSU website under the "Broadcast/Newsletter" tab. 

June 7, 2017
Dr. Wolmark recipient of 2017 Giants of Cancer Care® award in breast cancer

Norman Wolmark, MD, has been awarded the 2017 Giants of Cancer Care® award for recognition of his contributions in breast cancer research. The recipients of the 2017 Giants of Cancer Care® awards represent twelve categories in the field of oncology and were chosen by an elite group of oncologists and hematologists from more than 300 nominations by the oncology community. This year's award ceremony was held during a reception at the Chicago History Museum on June 1. Read more.

May 22, 2017
Memorial Day closures for Operations, SDMCs, Biospecimen and Serum Banks, and Biologics, Inc. Read more

March 14, 2017
NRG Oncology NCORP PILOT Projects
NRG Oncology NCORP is soliciting PILOT projects for applications focused on NRG NCORP Cancer Prevention and Control (CPC) priorities that will provide data that will directly lead to future Phase II-III  CPC concepts.  As put forward in our core grant, CPC priorities for funding are: 

  •  Cancer prevention research aimed at identifying and evaluating interventions to reduce the risk and incidence of cancer 
  •  Cancer control research aimed at reducing the incidence and co-morbidity of cancer and its treatment focused on the four symptomatic management  themes: neurotoxicity, cardiotoxicity, lymphedema, and inflammation (including cancer-related fatigue)
  •  Survivorship and palliative care interventions aimed at reducing toxicity and symptom burden, and improving quality of life (QoL)
  •  Cancer disparity research, in collaboration with our Health Disparities Research (HDR) Program, focused on efforts to increase the participation of  minorities and underserved populations in CPC studies
  •  Integral to these priorities, are the establishment of biospecimen repositories for molecular studies. 

For full details read more

NRG Oncology NCORP is soliciting PILOT projects for applications focused on NRG NCORP Cancer Care Delivery Research (CCDR) priorities that will provide data that will directly lead to future CCDR concepts.  As put forward in our core grant, CCDR priorities for funding are:

  • Implementation of guideline-based care
  • Patient-reported outcomes (PROs) 
  • Decision-making tools 
  • Patient navigation 
  • Cardiotoxicity 
  • Survivorship and surveillance 
For full details read more

 

March 14, 2017
CB-839 PTMA

CTEP has released a project team member application (PTMA) for CB-839 (Calithera Biosciences, Inc.). CTEP plans to sponsor four phase 1 combination trials of CB-839 for the treatment of NSCLC, soft tissue sarcoma, or glioma. The PTMA documents are on the NRG website here.

Interested applicants should notify NRG Oncology Leadership and submit PTMA to the appropriate protocol development office.

    Applicants, please submit the form to the NRG protocol development office by COB Monday, April 3, 2017. NRG Oncology will submit the application to CTEP by the deadline of April 10, 2017.




    Copyright 2017 by NRG Oncology